Medtronic Market Capitalization from 2010 to 2024
| MDT Stock | USD 86.54 0.27 0.31% |
Check Medtronic PLC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medtronic PLC's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.8 B, Interest Expense of 755 M or Total Revenue of 34 B, as well as many indicators such as Price To Sales Ratio of 5.85, Dividend Yield of 0.0177 or PTB Ratio of 3.42. Medtronic financial statements analysis is a perfect complement when working with Medtronic PLC Valuation or Volatility modules.
Medtronic | Market Capitalization |
Latest Medtronic PLC's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Medtronic PLC over the last few years. It is Medtronic PLC's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medtronic PLC's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 110.97 B | 10 Years Trend |
|
Market Cap |
| Timeline |
Medtronic Market Capitalization Regression Statistics
| Arithmetic Mean | 139,175,112,684 | |
| Geometric Mean | 136,726,351,410 | |
| Coefficient Of Variation | 19.91 | |
| Mean Deviation | 25,880,487,221 | |
| Median | 117,608,040,000 | |
| Standard Deviation | 27,704,156,959 | |
| Sample Variance | 767520312.8T | |
| Range | 58.5B | |
| R-Value | 0.81 | |
| Mean Square Error | 284125308.3T | |
| R-Squared | 0.66 | |
| Significance | 0.0003 | |
| Slope | 5,018,414,438 | |
| Total Sum of Squares | 10745284379.3T |
Medtronic Market Capitalization History
About Medtronic PLC Financial Statements
Medtronic PLC shareholders use historical fundamental indicators, such as Market Capitalization, to determine how well the company is positioned to perform in the future. Although Medtronic PLC investors may analyze each financial statement separately, they are all interrelated. The changes in Medtronic PLC's assets and liabilities, for example, are also reflected in the revenues and expenses on on Medtronic PLC's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The company was founded in 1949 and is headquartered in Dublin, Ireland. Medtronic operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 95000 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medtronic Stock Analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.